We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $61.4 · 15 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
A Look At BrightSpring Health Services (BTSG) Valuation After Upward Earnings Revisions And Strong Home Based Care Demand - simplywall.st
A Look At BrightSpring Health Services (BTSG) Valuation After Upward Earnings Revisions And Strong Home Based Care Demand simplywall.st
BrightSpring Health Services, Inc. (BTSG) is on the move, here's why the trend could be sustainable - MSN
BrightSpring Health Services, Inc. (BTSG) is on the move, here's why the trend could be sustainable MSN
How Brightspring Health Services Inc. (BTSG) Affects Rotational Strategy Timing - Stock Traders Daily
How Brightspring Health Services Inc. (BTSG) Affects Rotational Strategy Timing Stock Traders Daily
Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $62 - Moomoo
Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $62 Moomoo
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 31. | After market close (AMC) | $0.39 | — | — | $3.67B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.14 | — | — | $2.88B | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.18 | — | — | $7.33B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.14 | — | — | $4.72B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 07. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 05. 05. | Mizuho | — | Maintain | Outperform → Outperform | — | Mizuho: Outperform |
| 2026. 05. 05. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 05. 05. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 05. 04. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2026. 05. 04. | Stephens & Co. | — | Maintain | Overweight → Overweight | — | Stephens & Co.: Overweight |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.